HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cezmi Akdis Selected Research

Eczema

1/2017Mechanisms of the Development of Allergy (MeDALL): Introducing novel concepts in allergy phenotypes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cezmi Akdis Research Topics

Disease

10Asthma (Bronchial Asthma)
02/2024 - 06/2007
10Hypersensitivity (Allergy)
01/2023 - 05/2007
7Food Hypersensitivity (Food Allergy)
12/2021 - 01/2016
4Anaphylaxis (Anaphylactic Shock)
01/2022 - 05/2007
3Allergic Rhinitis
01/2023 - 06/2007
3Inflammation (Inflammations)
01/2019 - 11/2014
2Atopic Dermatitis (Atopic Eczema)
11/2020 - 11/2013
1Coinfection
11/2023
1Respiratory Sounds (Crackle)
11/2023
1Convalescence
11/2023
1Sepsis (Septicemia)
01/2022
1Chronic Disease (Chronic Diseases)
01/2020
1COVID-19
01/2020
1Drug Hypersensitivity (Drug Allergy)
12/2019
1Immediate Hypersensitivity
11/2018
1Rhinitis
01/2017
1Eczema
01/2017
1Infections
04/2015
1Communicable Diseases (Infectious Diseases)
04/2015
1Lymphoma (Lymphomas)
11/2013
1Neoplasms (Cancer)
11/2013
1Angioedema
04/2012
1Rhinosinusitis
06/2008

Drug/Important Bio-Agent (IBA)

10Immunoglobulin E (IgE)IBA
12/2021 - 05/2007
8AllergensIBA
01/2022 - 05/2007
3CytokinesIBA
11/2023 - 06/2008
3dupilumabIBA
01/2020 - 01/2020
2COVID-19 VaccinesIBA
12/2021 - 01/2021
2Immunoglobulin G (IgG)IBA
01/2021 - 06/2007
2benralizumabIBA
01/2020 - 01/2020
2Butyrates (Butyrate)IBA
01/2020 - 01/2019
2Monoclonal AntibodiesIBA
01/2020 - 01/2020
2Omalizumab (Xolair)FDA Link
01/2020 - 01/2020
11,3-dichloro-1-propene (1,3-dichloropropene)IBA
02/2024
1Air Pollutants (Pollutants, Air)IBA
02/2024
1Environmental Pollutants (Pollutants, Environmental)IBA
02/2024
1Chemokine CX3CL1IBA
11/2023
1Interleukin-8 (Interleukin 8)IBA
11/2023
1Epidermal Growth Factor (EGF)IBA
11/2023
1Iron-Dextran Complex (InFed)FDA Link
01/2023
1CannabinoidsIBA
01/2022
1Excipients (Suspending Agents)IBA
12/2021
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
12/2021
1Interleukin-13IBA
01/2021
1mRNA VaccinesIBA
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1VaccinesIBA
01/2021
1Interleukin-4 (Interleukin 4)IBA
01/2021
1Interleukin-5 (Interleukin 5)IBA
01/2021
1reslizumabIBA
01/2020
1Interleukin-4 Receptors (Interleukin 4 Receptor)IBA
01/2020
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2020
1Volatile Fatty AcidsIBA
01/2020
1mepolizumabIBA
01/2020
1insulin receptor-related receptor (IRR)IBA
01/2020
1PropionatesIBA
01/2019
1AntigensIBA
11/2018
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2015
1AutoantibodiesIBA
04/2015
1Volatile Organic CompoundsIBA
11/2014
1pimecrolimus (Elidel)FDA Link
11/2013
1Calcineurin InhibitorsIBA
11/2013
1Immunoglobulin A (IgA)IBA
06/2007
1Phospholipases A2 (Phospholipase A2)IBA
05/2007
1Hyaluronoglucosaminidase (Hyaluronidase)FDA Link
05/2007
1Bee Venoms (Bee Venom)IBA
05/2007

Therapy/Procedure

5Therapeutics
01/2022 - 04/2012
4Immunotherapy
12/2019 - 05/2007
2Precision Medicine
11/2020 - 01/2017
1Oral Administration
01/2019